Paper16633046
5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine.
Hande S and 9 others. Inflamm Bowel Dis, 2006. Cited by 84 papers, by iCite.
Cite this record
ConductScience Library. 5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine. Papers, record 16633046. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16633046
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Inflammatory Agents, Non-Steroidal | Major topic |
| Azathioprine | Major topic |
| Immunosuppressive Agents | Major topic |
| Inflammatory Bowel Diseases | Major topic |
| Mercaptopurine | Major topic |
| Mesalamine | Major topic |
| Thioguanine | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Biomarkers | |
| Child | |
| Cross-Sectional Studies | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Male | |
| Middle Aged | |
| Remission Induction | |
| Retrospective Studies | |
| Severity of Illness Index | |
| Treatment Outcome |
Source PubMed
Cited by37
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 84 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42663270 | Blood-test monitoring strategies for patients established on immune-suppressing drugs: a mixed-methods study. | Health Technol Assess | 2026 | https://conductscience.org/library/papers/42663270 | PubMed |
| 41846507 | The decline of 6-thioguanine nucleotides is not linked to impaired efficacy or safety of thiopurines in pregnant women with inflammatory bowel disease. | Br J Clin Pharmacol | 2026 | https://conductscience.org/library/papers/41846507 | PubMed |
| 40206080 | Proactive pharmacogenomics in azathioprine-treated pediatric inflammatory bowel disease at a Chinese tertiary hospital. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40206080 | PubMed |
| 39598554 | Drug Interaction-Informed Approaches to Inflammatory Bowel Disease Management. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/39598554 | PubMed |
| 38589597 | Real-world NUDT15 genotyping and thiopurine treatment optimization in inflammatory bowel disease: a multicenter study. | J Gastroenterol | 2024 | https://conductscience.org/library/papers/38589597 | PubMed |
| 38023976 | Concomitant 5-aminosalicylic acid treatment does not affect 6-thioguanine nucleotide levels in patients with inflammatory bowel disease on thiopurines. | Ann Gastroenterol | 2023 | https://conductscience.org/library/papers/38023976 | PubMed |
| 37959208 | The Role of Pharmacogenetics in the Therapeutic Response to Thiopurines in the Treatment of Inflammatory Bowel Disease: A Systematic Review. | J Clin Med | 2023 | https://conductscience.org/library/papers/37959208 | PubMed |
| 37745026 | Risk-stratified monitoring for thiopurine toxicity in immune-mediated inflammatory diseases: prognostic model development, validation, and, health economic evaluation. | EClinicalMedicine | 2023 | https://conductscience.org/library/papers/37745026 | PubMed |
| 34797442 | No Benefit of Continuing 5-Aminosalicylates in Patients with Crohn's Disease Treated with Anti-metabolite Therapy. | Dig Dis Sci | 2022 | https://conductscience.org/library/papers/34797442 | PubMed |
| 34487330 | Advances in Thiopurine Drug Delivery: The Current State-of-the-Art. | Eur J Drug Metab Pharmacokinet | 2021 | https://conductscience.org/library/papers/34487330 | PubMed |
| 33929082 | Xanthine oxidase activity in thiopurine curative Chinese inflammatory bowel disease patients. | Pharmacol Res Perspect | 2021 | https://conductscience.org/library/papers/33929082 | PubMed |
| 33755823 | Thiopurine Monotherapy Is Effective in Maintenance of Mild-Moderate Inflammatory Bowel Disease. | Dig Dis Sci | 2022 | https://conductscience.org/library/papers/33755823 | PubMed |
| 32668748 | Thiopurines' Metabolites and Drug Toxicity: A Meta-Analysis. | J Clin Med | 2020 | https://conductscience.org/library/papers/32668748 | PubMed |
| 32573825 | No benefit of continuing vs stopping 5-aminosalicylates in patients with ulcerative colitis escalated to anti-metabolite therapy. | Aliment Pharmacol Ther | 2020 | https://conductscience.org/library/papers/32573825 | PubMed |
| 29752633 | Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Ulcerative Colitis. | Clin Pharmacokinet | 2019 | https://conductscience.org/library/papers/29752633 | PubMed |
| 28839543 | Optimising use of thiopurines in inflammatory bowel disease. | Frontline Gastroenterol | 2010 | https://conductscience.org/library/papers/28839543 | PubMed |
| 28028358 | Thiopurines and inflammatory bowel disease: Current evidence and a historical perspective. | World J Gastroenterol | 2016 | https://conductscience.org/library/papers/28028358 | PubMed |
| 27082580 | Prospective Evaluation of Pharmacogenomics and Metabolite Measurements upon Azathioprine Therapy in Inflammatory Bowel Disease: An Observational Study. | Medicine (Baltimore) | 2016 | https://conductscience.org/library/papers/27082580 | PubMed |
| 26360046 | A Prospective Study Evaluating Metabolic Capacity of Thiopurine and Associated Adverse Reactions in Japanese Patients with Inflammatory Bowel Disease (IBD). | PLoS One | 2015 | https://conductscience.org/library/papers/26360046 | PubMed |
| 26255287 | Pharmacology and Optimization of Thiopurines and Methotrexate in Inflammatory Bowel Disease. | Clin Pharmacokinet | 2016 | https://conductscience.org/library/papers/26255287 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TPMT | 7172 | PubTator's text mining | https://conductscience.org/library/genes/7172 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16633046
GET https://conductscience.org/api/papers/v1/16633046/cited_by?page=2